1445 related articles for article (PubMed ID: 29111341)
1. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
[TBL] [Abstract][Full Text] [Related]
2. Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis.
Liu H; Zheng H; Cao Y; Pan Y; Wang D; Zhang R; You S; Zhang X; Li S; Tong X; Liu CF; Wang Y
J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):988-997. PubMed ID: 29224744
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
Yeo LL; Kong WY; Paliwal P; Teoh HL; Seet RC; Soon D; Rathakrishnan R; Ong V; Lee TH; Wong HF; Chan BP; Leow WK; Yuan C; Ting E; Gopinathan A; Tan BY; Sharma VK
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361
[TBL] [Abstract][Full Text] [Related]
4. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.
Minhas JS; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Donnan GA; Kim JS; Lavados PM; Lee TH; Martins SCO; Olavarría VV; Pandian JD; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Thang NH; Wang JG; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Cerebrovasc Dis; 2018; 45(5-6):213-220. PubMed ID: 29705803
[TBL] [Abstract][Full Text] [Related]
5. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
Ong CT; Wong YS; Wu CS; Su YH
Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
[TBL] [Abstract][Full Text] [Related]
6. Impact of Tissue Plasminogen Activator Dosing on Patients Weighing More Than 100 kg on 3-Month Outcomes in Acute Ischemic Stroke.
Garavaglia J; Sherman J; Yetzer H; Regier M; Smith M
J Stroke Cerebrovasc Dis; 2017 May; 26(5):1041-1046. PubMed ID: 28129994
[TBL] [Abstract][Full Text] [Related]
7. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
[TBL] [Abstract][Full Text] [Related]
8. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
[TBL] [Abstract][Full Text] [Related]
9. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Tissue Plasminogen Activator in Stroke Mimics.
Ali-Ahmed F; Federspiel JJ; Liang L; Xu H; Sevilis T; Hernandez AF; Kosinski AS; Prvu Bettger J; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC; Peterson ED; Xian Y
Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005609. PubMed ID: 31412730
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous Thrombolytics.
Behrouz R; Masjuán-Vallejo J; Vera R; Willey JZ; Zedet M; Moulin S; Cordonnier C; Klijn CJM; Kanselaar K; Dirks M; Silver B; Khan M; Azarpazhooh MR; Godoy DA; Roffe C; Paley L; Bray BD; Smith CJ; Di Napoli M;
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):246-256. PubMed ID: 28935502
[TBL] [Abstract][Full Text] [Related]
12. Effect of Pretreatment Blood Pressure on Outcomes in Thrombolysed Acute Ischemic Stroke Patients: A Systematic Review and Meta-analysis.
Teng RSY; Tan BYQ; Miny S; Syn NL; Ho AFW; Ngiam NJH; Yeo LLL; Choong AM; Sharma VK
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):906-919. PubMed ID: 30612890
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in Singapore.
Sharma VK; Tsivgoulis G; Tan JH; Wong LY; Ong BK; Chan BP; Teoh HL
J Stroke Cerebrovasc Dis; 2010; 19(6):424-30. PubMed ID: 20554224
[TBL] [Abstract][Full Text] [Related]
15. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study.
Wang X; Song L; Yang J; Sun L; Moullaali TJ; Sandset EC; Delcourt C; Lindley RI; Robinson TG; Minhas JS; Arima H; Chalmers J; Kim JS; Sharma V; Wang JG; Pontes-Neto O; Lavados PM; Olavarría VV; Lee TH; Levi C; Martins SO; Thang NH; Anderson CS;
Cerebrovasc Dis; 2019; 48(3-6):207-216. PubMed ID: 31812956
[TBL] [Abstract][Full Text] [Related]
16. Comparative Analysis on Low- and Standard-Dose Regimes of Alteplase Thrombolytic Therapy for Acute Ischemic Stroke: Efficacy and Safety.
Zhao G; Huang T; Zheng M; Cui Y; Liu Y; Cheng Z; Wang Z
Eur Neurol; 2018; 79(1-2):68-73. PubMed ID: 29241193
[TBL] [Abstract][Full Text] [Related]
17. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
[TBL] [Abstract][Full Text] [Related]
18. A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke.
Adeoye O; Knight WA; Khoury J; Schmit PA; Sucharew H; Broderick JP; Pancioli AM;
J Stroke Cerebrovasc Dis; 2014; 23(5):e313-5. PubMed ID: 24534128
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
[TBL] [Abstract][Full Text] [Related]
20. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
